# Jushi Holdings Settles Hemp Product Litigation Case > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/hemp-product-litigation-jushi-holdings-settlement/ > **Published:** 2026-03-26T18:06:13-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:37:12-04:00 > **Clinical Summary:** Explore the latest on hemp product litigation with Jushi Holdings' settlement, highlighting regulatory compliance and product safety concerns. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic [Hemp Products](https://cedclinic.com/texas-hemp-stricter-thc-rules-march-31-2026/)Product SafetyRegulatory Compliance[Quality Control](https://cedclinic.com/alabama-medical-cannabis-commission-audit-violations/)[Legal Issues](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/) Why This Matters Legal settlements in hemp product litigation signal ongoing regulatory uncertainty and [quality control](https://cedclinic.com/alabama-medical-cannabis-commission-audit-violations/) issues that directly impact patient safety and clinical confidence in recommending specific products. This reflects the broader challenge clinicians face in navigating an unregulated hemp market where product claims may not match actual contents or safety profiles. Clinical Summary Jushi Holdings has reached an undisclosed settlement in litigation related to [hemp products](https://cedclinic.com/texas-hemp-stricter-thc-rules-march-31-2026/), though specific details of the underlying claims or alleged issues are not provided in the available information. This represents one of numerous legal challenges facing hemp and cannabis companies as the industry operates within evolving regulatory frameworks. Such settlements typically involve product liability, marketing claims, or regulatory compliance issues that affect consumer and patient confidence in hemp-derived products. Dr. Caplan’s Take “Without knowing the specific allegations, this settlement reminds me why I emphasize third-party testing and regulatory compliance when discussing hemp products with patients. Legal actions often reveal quality control gaps that aren’t immediately visible to consumers or prescribing clinicians.” Clinical Perspective 🧠 Clinicians should continue emphasizing the importance of third-party lab testing, clear labeling, and reputable sourcing when patients inquire about hemp products. This settlement underscores the need for patients to research manufacturers’ compliance history and quality standards rather than relying solely on marketing claims or brand recognition. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Jushi%20Holdings%20reaches%20first%20settlement%20in%20hemp%20product%20lawsuit%20-%20MMJDaily%20%40drcaplan&url=https%3A//www.mmjdaily.com/article/9823779/jushi-holdings-reaches-first-settlement-in-hemp-product-lawsuit/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.mmjdaily.com/article/9823779/jushi-holdings-reaches-first-settlement-in-hemp-product-lawsuit/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Jushi%20Holdings%20reaches%20first%20settlement%20in%20hemp%20product%20lawsuit%20-%20MMJDaily%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.mmjdaily.com/article/9823779/jushi-holdings-reaches-first-settlement-in-hemp-product-lawsuit/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.mmjdaily.com/article/9823779/jushi-holdings-reaches-first-settlement-in-hemp-product-lawsuit/](https://www.mmjdaily.com/article/9823779/jushi-holdings-reaches-first-settlement-in-hemp-product-lawsuit/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What type of cannabis products does this article focus on?](#What_type_of_cannabis_products_does_this_article_focus_on) - [Why is product safety a key concern for hemp products?](#Why_is_product_safety_a_key_concern_for_hemp_products) - [What does regulatory compliance mean for hemp products?](#What_does_regulatory_compliance_mean_for_hemp_products) - [How important is quality control in hemp product manufacturing?](#How_important_is_quality_control_in_hemp_product_manufacturing) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/) should monitor closely. #### What type of cannabis products does this article focus on? The article specifically focuses on hemp products and their associated regulatory and safety considerations. Hemp products are cannabis-derived items that typically contain low levels of THC and are subject to specific regulatory frameworks. #### Why is product safety a key concern for hemp products? Product safety is crucial because hemp products can vary significantly in quality, potency, and purity without proper oversight. Consumers and healthcare providers need assurance that these products meet safety standards and contain accurate labeling of their contents. #### What does regulatory compliance mean for hemp products? Regulatory compliance refers to hemp products meeting federal, state, and local legal requirements for production, testing, and distribution. This includes adhering to THC limits, proper labeling requirements, and following manufacturing guidelines established by regulatory agencies. #### How important is quality control in hemp product manufacturing? Quality control is essential to ensure consistent potency, purity, and safety of hemp products. Proper quality control measures include testing for contaminants, verifying cannabinoid content, and maintaining standardized manufacturing processes to protect consumer health. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Jushi Holdings reaches first settlement in hemp product lawsuit – MMJDaily”, “url”: “https://www.mmjdaily.com/article/9823779/jushi-holdings-reaches-first-settlement-in-hemp-product-lawsuit/”, “datePublished”: “2026-03-26T19:54:04Z”, “about”: “jushi holdings reaches first settlement hemp”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Product Liability Claims | Practical Law The Journal | Reuters](https://cedclinic.com/cannabis-product-liability-law-patient-safety-claims/) An in-depth look at liability claims affecting cannabis products, providing legal context relevant to hemp product litigation. [Read More](https://cedclinic.com/cannabis-product-liability-law-patient-safety-claims/) [Dr. Rand Paul Introduces the Bipartisan Hemp Safety Enforcement Act](https://cedclinic.com/hemp-safety-enforcement-act-federal-standards/) Learn about new legislative efforts aimed at improving [hemp product safety](https://cedclinic.com/pediatric-cannabinoid-ingestions-preventable-overdose-risks/) and regulatory enforcement. [Learn More](https://cedclinic.com/hemp-safety-enforcement-act-federal-standards/) [New hemp rules go into effect – YouTube](https://cedclinic.com/hemp-regulatory-changes-impact-patient-access/) Watch the latest updates on hemp regulatory changes that impact product safety and compliance standards. [Watch Now](https://cedclinic.com/hemp-regulatory-changes-impact-patient-access/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).